Company: DMAC
Filing Date: 2025-02-24
Form Type: 8-K
Source: 0001437749-25-004891
Chunk: 2

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-02-24
Form: 8-K
Item: Item 5.02
Chunk 2
---
 Board, the Company entered into a standard indemnification agreement with Mr. O’ Connor, in substantially the same form that the Company has entered into with its other non-employee directors, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

There are no arrangements or understandings between Mr. O’ Connor and any other persons pursuant to which he was selected as a director and no transaction since the beginning of the Company’s last fiscal year, or any currently proposed transaction, which the Company was or is to be a participant and in which or any related person had or will have a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Securities and Exchange Commission Regulation S-K.

Item 7.01Regulation FD Disclosure.